Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wiesneth

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Leukemia|March 29, 2014
Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapyV Schneider, L Zhang, L Bullinger, et al.
Bone Marrow Transplantation|August 5, 2000
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cellsG Hale, P Jacobs, L Wood, et al.
Blood|July 27, 2001
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II studyD Bunjes, I Buchmann, C Duncker, et al.
Vox Sanguinis|June 10, 2010
Preparation of granulocyte concentrates by apheresisG Leitner, S Panzer, H W Reesink, et al.
Vox Sanguinis|September 20, 2011
Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow)K Rosskopf, S J Ragg, N Worel, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Leukemia|March 29, 2014
Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapyV Schneider, L Zhang, L Bullinger, et al.
Bone Marrow Transplantation|August 5, 2000
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cellsG Hale, P Jacobs, L Wood, et al.
Blood|July 27, 2001
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II studyD Bunjes, I Buchmann, C Duncker, et al.
Vox Sanguinis|June 10, 2010
Preparation of granulocyte concentrates by apheresisG Leitner, S Panzer, H W Reesink, et al.
Vox Sanguinis|September 20, 2011
Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow)K Rosskopf, S J Ragg, N Worel, et al.
Pageof 8